PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAntares Pharma
Antares Pharma(ATRS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
SumatriptanSumatriptan2015-12-102024-2036
Migraine disorders
,
Cluster headache
,
Juvenile arthritis
,
Ankylosing spondylitis
,
Rheumatoid arthritis
,
Headache
,
Fever
,
Inflammation
,
Osteoarthritis
,
Bursitis
,
Back pain
,
Common cold
,
Toothache
,
Dysmenorrhea
,
Gout
XyostedTestosterone enanthate2018-09-282024-2039
Breast neoplasms
,
Hypogonadism
,
Delayed puberty
,
Prostatic neoplasms
,
Menorrhagia
,
Primary ovarian insufficiency
,
Hot flashes
,
Premature menopause
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Testosterone enanthate
hypogonadism
,
menopause
,
cardiovascular diseases
Polyglycolic acid
t-cell lymphoma cutaneous
,
mycoses
,
sezary syndrome
,
large-cell lymphoma anaplastic
,
primary cutaneous anaplastic large cell lymphoma
,
mycosis fungoides
,
non-hodgkin lymphoma
,
lymphoma
,
t-cell lymphoma
,
t-cell lymphoma peripheral
,
mucositis
,
hematologic neoplasms
,
breast neoplasms
,
carcinoma
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
neoplasms
,
hodgkin disease
,
waldenstrom macroglobulinemia
,
b-cell lymphoma
Sustanon
hypogonadism
,
cardiovascular diseases
,
healthy volunteers/patients
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use